The University of Glasgow’s Small Animal Hospital has become the first UK centre to offer venom immunotherapy for dogs with serious allergic reactions to bee and wasp stings. The treatment, Hymenoptera Venom Immunotherapy (VIT), involves administering venom extracts in a controlled medical process to help desensitise affected dogs. Phys.org reports that the therapy has been successfully used in a number of patients at the hospital. Clinicians describe the approach as still relatively new, but say it is intended to reduce the risk of recurrent anaphylaxis. Both sources frame the initiative as a significant step in veterinary allergy care within the UK, with the Glasgow hospital leading early adoption of the method. The reports focus on the hospital’s role in introducing the therapy and on its potential to prevent repeated severe reactions in dogs that experience anaphylaxis after stings. No additional details on timelines, eligibility criteria, or comparative outcomes are provided in the excerpts.